Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
EXPERIENCE AND REASON

The Use of Recombinant Activated Factor VII to Control Bleeding in a Preterm Infant Undergoing Exploratory Laparotomy

Ampaiwan Chuansumrit, Pracha Nuntnarumit, Chusak Okascharoen, Sumete Teeraratkul, Saranya Suwansingh and Sarayut Supapannachart
Pediatrics July 2002, 110 (1) 169-171; DOI: https://doi.org/10.1542/peds.110.1.169
Ampaiwan Chuansumrit
*Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pracha Nuntnarumit
*Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chusak Okascharoen
*Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumete Teeraratkul
‡Surgery Ramathibodi Hospital Mahidol University Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saranya Suwansingh
*Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarayut Supapannachart
*Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • Comments
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF

Abstract

The case of a preterm infant weighing 1120 g who successfully received recombinant activated factor VII (rFVIIa) without complication for control of a life-threatening bleeding event resulting from a ruptured umbilical artery is reported. After performing an exploratory laparotomy at 27 hours of age, hemorrhage from the surgical wound and various sites persisted. By 63 hours of age, the infant had received a total of 192 mL (171 mL/kg) of packed red blood cells, 115 mL (103 mL/kg) of fresh frozen plasma, 8 mL of cryoprecipitate, and 75 mL (67 mL/kg) of platelet concentrate without stabilization. Hemorrhage ceased after 2 doses of 40 μg/kg/dose recombinant activated factor VII given at 63 and 70 hours of age, with subsequent stabilization of the hematocrit and without need for additional transfusion therapy.

  • rFVIIa
  • preterm
  • bleeding
  • Received June 25, 2001.
  • Accepted January 14, 2002.
  • Copyright © 2002 by the American Academy of Pediatrics

Individual Login

Log in
You will be redirected to aap.org to login or to create your account.

Institutional Login

via Institution

You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

Offer Reprints

PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 110, Issue 1
1 Jul 2002
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Use of Recombinant Activated Factor VII to Control Bleeding in a Preterm Infant Undergoing Exploratory Laparotomy
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
The Use of Recombinant Activated Factor VII to Control Bleeding in a Preterm Infant Undergoing Exploratory Laparotomy
Ampaiwan Chuansumrit, Pracha Nuntnarumit, Chusak Okascharoen, Sumete Teeraratkul, Saranya Suwansingh, Sarayut Supapannachart
Pediatrics Jul 2002, 110 (1) 169-171; DOI: 10.1542/peds.110.1.169

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Use of Recombinant Activated Factor VII to Control Bleeding in a Preterm Infant Undergoing Exploratory Laparotomy
Ampaiwan Chuansumrit, Pracha Nuntnarumit, Chusak Okascharoen, Sumete Teeraratkul, Saranya Suwansingh, Sarayut Supapannachart
Pediatrics Jul 2002, 110 (1) 169-171; DOI: 10.1542/peds.110.1.169
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Unlabeled uses of factor VIIa (recombinant) in pediatric patients
  • Google Scholar

More in this TOC Section

  • Invasive Pulmonary and Central Nervous System Aspergillosis After Near-Drowning of a Child: Case Report and Review of the Literature
  • Intracranial Hemorrhage as the Initial Manifestation of a Congenital Disorder of Glycosylation
  • Thoracolumbar Syrinx in Association With Williams Syndrome
Show more EXPERIENCE AND REASON

Similar Articles

Subjects

  • Hematology/Oncology
    • Hematology/Oncology

Keywords

  • rFVIIa
  • preterm
  • bleeding
  • rFVIIa, recombinant activated factor VIIa
  • LP-PRBC, leukocyte-poor packed red blood cells
  • FFP, fresh frozen plasma
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics